Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - USD ($)
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2018 $ 13 $ 341,529 $ 30,669,220 $ (43,890,445) $ (12,879,683)
Beginning Balance, Shares at Dec. 31, 2018 13,000 34,152,943      
Share-based compensation from issuance of options and compensation-based warrants 577,645 577,645
Exercise of stock options $ 2,500 12,500 12,500
Exercise of stock options, Shares 250,000      
Net Loss (11,791,819) (11,791,819)
Ending Balance at Dec. 31, 2019 $ 13 $ 344,029 31,259,365 (55,682,264) (24,078,857)
Ending Balance, Shares at Dec. 31, 2019 13,000 34,402,943      
Share-based compensation from issuance of options and compensation-based warrants 326,486 326,486
Exercise of stock options $ 14,470 76,326 90,796
Exercise of stock options, Shares 1,447,017      
Option grants for investment in subsidiaries 5,477,677 5,477,677
Net Loss (10,550,175) (10,550,175)
Ending Balance at Dec. 31, 2020 $ 13 $ 358,499 $ 37,139,854 $ (66,232,439) $ (28,734,073)
Ending Balance, Shares at Dec. 31, 2020 13,000 35,849,960